$HIMS (-1,33%) about the $NOVO B (-0,2%) partnership:
"More importantly, beyond this initial launch, we are developing a broader roadmap together with Novo Nordisk, as well as a blueprint for future partnerships"
This is going to be exciting...
$HIMS (-1,33%) about the $NOVO B (-0,2%) partnership:
"More importantly, beyond this initial launch, we are developing a broader roadmap together with Novo Nordisk, as well as a blueprint for future partnerships"
This is going to be exciting...